8-Chloro-1-cyclopropyl-7-[2-(dimethylamino)ethoxy]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride | 126496-24-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 8-Chloro-1-cyclopropyl-7-[2-(dimethylamino)ethoxy]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride
• 英文别名: 8-Chloro-1-cyclopropyl-7-[2-(dimethylamino)ethoxy]-6-fluoro-4-oxoquinoline-3-carboxylic acid;hydrochloride
• CAS: 126496-24-0
• 化学式: C₁₇H₁₈ClFN₂O₄*ClH
• 分子量: 405.253
• InChiKey: ZTEPBSIORFDQON-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.19
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  70.1
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  1-Cyclopropyl-7-[2-(dimethylamino)ethoxy]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 、 异丙醚 在 sodium hydroxide 作用下， 以 氯磺酸 为溶剂， 生成 8-Chloro-1-cyclopropyl-7-[2-(dimethylamino)ethoxy]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride
  参考文献：
  名称：

  Quinoline-3-carboxylic acid derivatives, process for preparing the same, and composition exhibiting excellent antibacterial effect containing the same

  摘要：

  式(I)所示的喹啉-3-羧酸衍生物；其中R1为氢原子或氨基；R2为氢原子或低级烷基，或R2与R4结合形成具有1至4个亚甲基的亚烷基；R3和R4相同或不同，各自为氢原子或低级烷基，或R3与R4结合形成具有2至6个亚甲基的亚烷基；R5和R6相同或不同，各自为氢原子或低级烷基，或R5与R2结合形成具有1至4个亚甲基的亚烷基，或R5与R3结合，连同相邻的氮原子，形成可被取代的5至7元环系，或R5与R6结合，连同相邻的氮原子，形成可被取代的5至7元环系；A为氧原子或硫原子；n选自0至3，及其药理学上可接受的盐，这些衍生物显示出优异的抗菌效果，它们的制备方法，包含它们的药物组合物，以及通过给予此类化合物治疗受细菌感染的个体的方法，均被公开。

  公开号：

  EP0339406A1

文献信息

• Quinoline-3-carboxylic acid derivatives, process for preparing the same, and composition exhibiting excellent antibacterial effect containing the same
  申请人：Hokuriku Pharmaceutical Co.,Ltd

  公开号：EP0339406A1

  公开（公告）日：1989-11-02

  Quinoline-3-carboxylic acid derivatives represented by the formula (I); wherein R1 is a hydrogen atom or an amino group; R2 is a hydrogen atom or a lower-alkyl group, or R2 combined with R4 is an alkylene group having 1 through 4 methylenes; R3 and R4. are the same or different and each is a hydrogen atom or a lower-alkyl group, or R3 combined with R4 is an alkylene group having 2 through 6 methylenes; Rs and Rs are the same or different and each is a hydrogen atom or a lower-alkyl group, or Rs combined with R2 is an alkylene group having 1 through 4 methylenes, or R5 combined with R3, together with the neighboring nitrogen atom, is a 5- through 7- membered ring system which may be substituted, or Rs and Rs, together with the neighboring nitrogen atom, is a 5-through 7- membered ring system which may be substituted; A is an oxygen atom or a sulfur atom; n is selected from 0 through 3, and pharmacologically-acceptable salts thereof, which exhibit excellent antibacterial effect, a process for their preparation, pharmaceutical compositions thereof, and a method for the treatment of a subject afflicted with bacterial infections by administrating such a compound, are all disclosed.

  式(I)所示的喹啉-3-羧酸衍生物；其中R1为氢原子或氨基；R2为氢原子或低级烷基，或R2与R4结合形成具有1至4个亚甲基的亚烷基；R3和R4相同或不同，各自为氢原子或低级烷基，或R3与R4结合形成具有2至6个亚甲基的亚烷基；R5和R6相同或不同，各自为氢原子或低级烷基，或R5与R2结合形成具有1至4个亚甲基的亚烷基，或R5与R3结合，连同相邻的氮原子，形成可被取代的5至7元环系，或R5与R6结合，连同相邻的氮原子，形成可被取代的5至7元环系；A为氧原子或硫原子；n选自0至3，及其药理学上可接受的盐，这些衍生物显示出优异的抗菌效果，它们的制备方法，包含它们的药物组合物，以及通过给予此类化合物治疗受细菌感染的个体的方法，均被公开。